AzTrials
AzTrials

Adherence, PatientNCT03710213

Automated Navigation to Improve Outpatient Colonoscopy Adherence

A study testing Text Message-based Intervention in people with Adherence, Patient and Colonoscopy, run by University of Pennsylvania at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Outpatient colonoscopy adherence is negatively impacted by poor communication and challenges with bowel preparation. We plan to perform a randomized controlled trial at the Pennsylvania Presbyterian Medical Center to (1) provide text message-based educational and reminder messages to patients regarding a scheduled… Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Adherence, Patient, Colonoscopy, Text Messaging
What is being tested?
Text Message-based Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
752 participants
Where
1 siteUnited States
Study dates
26 Nov 2018to 18 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Scheduled for outpatient colonoscopy at Pennsylvania Presbyterian Medical Center
  • Subject has a cell phone with enabled text messaging capability

Who cannot join

  • Fewer than 14 days between the time of enrollment and time of scheduled colonoscopy
  • Subject is non-English speaking requiring a translator
  • Subject is not the primary individual receiving the text messages

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Pennsylvania Hospital System

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: Automated Text Message Navigation to Improve Outpatient Colonoscopy Show Rate and Bowel Preparation

Outpatient colonoscopy adherence is negatively impacted by poor communication and challenges with bowel preparation. We plan to perform a randomized controlled trial at the Pennsylvania Presbyterian Medical Center to (1) provide text message-based educational and reminder messages to patients regarding a scheduled colonoscopy, and (2) evaluate the impact of the texting intervention on colonoscopy show rate and bowel preparation.

Read the detailed description

Colorectal cancer (CRC) is the second leading cause of cancer death in the US, yet there are effective screening and treatment strategies that allow for early detection and treatment. CRC screening is recommended for all individuals aged 50-75, which could include stool testing or colonoscopy, but national rates are still suboptimal at 59-65%. Colonoscopy is an essential component of CRC screening, as it is also required if stool testing is positive. However, colonoscopy requires a complex process to identify an escort, purchase the preparation, take a day off from work, adhere to a clear liquid diet, and complete the split-dose preparation as recommended. This results in a significant no-show and cancellation rate, along with suboptimal preparation quality, which can lead to non-adherence and incomplete screening.

Current approaches to engaging patients include having nurses call patients before the procedure or patient navigators. However, it is often difficult to get patients on the phone, and these interventions can be costly, making it less scalable for clinical practices. Other interventions such as videos or mobile apps have been limited by poor user experience or limited engagement with the patient. There is an opportunity to leverage an automated text message navigation intervention using the Way to Health (WTH) platform to improve patient engagement prior to colonoscopy completion. The WTH platform is a Penn Medicine platform that is hosted on site at the University of Pennsylvania. The platform allows custom text messages to automatically be sent to patients, in addition to bidirectional message capabilities. WTH is protected by a secure firewall and is a HIPAA compliant platform.

In the past year, our team conducted a quality improvement pilot initiative using WTH that tested the feasibility and impact of a one-week text messaging protocol for patients who were scheduled for outpatient colonoscopy. The text messages sent to patients contained information about the preparation process and instructions, expectations about the procedure, and reminders about location and timing. Among the 21 patients enrolled in the pilot, we found high user acceptability and higher colonoscopy show rates as compared to baseline values at Pennsylvania Presbyterian Medical Center. As such we believe that the texting intervention is feasible for testing in the context of a randomized controlled trial.

Being tested
Text Message-based Intervention
Medical subject headings
Patient Compliance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Text Message-based InterventionBehavioural

    The intervention consists of a series of educational and reminder text messages that a patient will receive in the week prior to a scheduled colonoscopy, in addition to two text messages at the time of enrollment explaining the texting program.

Study groups in NCT03710213
Study groupRoleWhat they receive
Usual CareNo interventionUsual care includes (1) bowel preparation instructions that are delivered via mail or through a secure online messaging portal, (2) a phone call from the endoscopy staff in the week prior to colonoscopy, and (3) the option to call the endoscopy staff during business hours to have any questions answered on demand.
Text Message-based InterventionExperimentalIn addition to usual care, the text message-based intervention consists of the subject receiving text messages per a pre-determined protocol starting 7 days prior to the date of scheduled colonoscopy, in addition to two text messages at the time of enrollment explaining the texting program. Of note, if a patient in the intervention arm cancels or reschedules their colonoscopy after randomization, they will not receive any additional protocol text messages as part of this trial.
Receives: Behavioral: Text Message-based Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Colonoscopy show rate with good or excellent bowel prep

    The proportion of patients who show up to their scheduled colonoscopy appointment and have a good or excellent prep

    Measured: Assessed on day of colonoscopy

Secondary outcomes (6)
  1. Colonoscopy show rate

    The proportion of patients who show up to their scheduled colonoscopy appointment

    Measured: Assessed on day of colonoscopy

  2. Bowel preparation quality

    The grading of bowel preparation quality (poor, fair, adequate, good, excellent) among those patients who show to their scheduled colonoscopy

    Measured: Assessed on day of originally-scheduled colonoscopy

  3. Colonoscopy cancellation rate

    The proportion of patients who cancel their originally scheduled colonoscopy appointment

    Measured: Assessed on day of originally-scheduled colonoscopy

  4. Colonoscopy reschedule rate

    The proportion of patients who cancel and reschedule (for a future date) on the same day, at least one day prior to the originally scheduled colonoscopy appointment date

    Measured: Assessed on day of originally-scheduled colonoscopy

  5. Colonoscopy no-show rate

    The proportion of patients who do not show for their scheduled colonoscopy appointment and who have not canceled

    Measured: Assessed on day of originally-scheduled colonoscopy

  6. Timing of advance cancellation notification (in days)

    The number of days in advance that a patient cancels their scheduled colonoscopy

    Measured: Assessed on day of originally-scheduled colonoscopy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2018
  2. Study start26 Nov 2018
  3. Primary completion18 Sep 2019
  4. Study completion18 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
752 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03710213
Sponsor's protocol ID
831701
Status last verified
Jan 2020
First submitted
15 Oct 2018
Last updated
6 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mahmud N, Asch DA, Sung J, Reitz C, Coniglio MS, McDonald C, Bernard D, Mehta SJ. Effect of Text Messaging on Bowel Preparation and Appointment Attendance for Outpatient Colonoscopy: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jan 4;4(1):e2034553. doi: 10.1001/jamanetworkopen.2020.34553.

    PubMed 33492374

Questions about this trial

What is this clinical trial studying?

A study testing Text Message-based Intervention in people with Adherence, Patient and Colonoscopy, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Colonoscopy show rate with good or excellent bowel prep (time frame: Assessed on day of colonoscopy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03710213, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in